Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Viridien and SLB complete the data acquisition for a multi-client survey in Bonaparte Basin, offshore Australia
-
Akastor ASA: DDW Offshore secures two contracts with an international oil company
-
Essity: Interim Report, Quarter 3, 2024
-
Axway: Q3 Group Revenue of €112.4m, with Organic Growth of 14.9%
-
APRU Leading the Way in Education in Disaster Risk Reduction
-
Eramet: Adjusted turnover of €809m in Q3 2024
-
Novartis ribociclib (Kisqali®) recognized as Category 1 preferred breast cancer adjuvant treatment by NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)
-
Authority Builders Shares Expert Insight on SEO Strategy Evolution Following Google Link Spam Update
-
Founder of Hua Medicine Dr. Li CHEN was awarded the "C.C. Tan Life Science Industrialization Award"
-
The HOTH Upsells Comprehensive SEO Audits with Expert Insights
-
The HOTH Upsells Comprehensive SEO Audits with Expert Insights
-
Hydro reduces ownership in Vianode
-
TGS Quarterly Dividend
-
Hydro reduces ownership in Vianode
-
Sonim XP100 Rugged Feature Phone Now Available in Europe
-
Sonim XP100 Rugged Feature Phone Now Available in Europe
-
Sonim XP100 Rugged Feature Phone Now Available in Europe
-
Azelis Reports Improving Performance in 9M 2024
-
Galderma Delivers Record Net Sales of 3.259 B USD in the First Nine Months of 2024, Demonstrates Significant Innovation Progress, Confirms and Narrows Its Full Year Net Sales Guidance
-
European Energy Infrastructure Company Snam Embarks on Strategic Sustainable Project with Dassault Systèmes’ 3DEXPERIENCE Platform
-
Vanta Introduces EU AI Act Support for the Ethical Development and Use of AI in Europe
-
"K" LINE to trial Inmarsat Maritime's new bonded network service NexusWave on "K" LINE's fleet
-
Norsk Hydro: Strong upstream results, building downstream robustness
-
Sodexo: strong financial delivery in Fiscal 2024
-
Kitron: Q3 2024 - Adapting to global market shifts
-
Start of Day Message
-
Eramet regains full ownership in its flagship Lithium business in Argentina
-
TGS announces Q3 2024 results
-
Pharming Group reports third quarter 2024 financial results and provides business update
-
Maisons du Monde: Third-Quarter and Nine-Month Sales 2024
-
Kinepolis posts strong third quarter
-
PolTREG launches Phase 2 cell therapy trial in children with presymptomatic diabetes
-
Renault Group 2024 Q3 revenue: +5.0% at constant exchange rates; FY 2024 financial outlook confirmed
-
Technip Energies and Enerkem formalize collaboration to advance waste-to-sustainable fuels and circular chemicals technology
-
Steady progress on Ontex’s transformation, realizing key strategic milestones, while continuing to deliver solid results
-
Telia Lietuva results for 9 months of 2024
-
WISeKey Launches its Enhanced INeS AI Security Broker Solution
-
Verkkokauppa.com Oyj Interim Report for 1 January–30 September 2024: Challenging operating environment and active inventory measures weighed down third quarter profitability
-
Central Bank of Savings Banks Finland Plc, Sp Mortgage Bank Plc & Savings Banks Group: Release of Financial Statements for 2024 will be published on 13th of February 2025
-
EfTEN Real Estate Fund AS unaudited results for 3rd quarter and nine months of 2024
-
argenx to Report Third Quarter 2024 Financial Results and Business Update on October 31, 2024
-
Dassault Systèmes: Third quarter results in-line - Anticipating top line acceleration in 4Q - Confirming full year EPS objective
-
Dassault Systèmes: European Energy Infrastructure Company Snam Embarks on Strategic Sustainable Project with Dassault Systèmes’ 3DEXPERIENCE Platform
-
Regenic Medical Group and Enju Planning Pte Ltd Forge Strategic Alliance to Establish 50 State-of-the-Art Medical Outlets Across Asia
-
Equinor to commence fourth tranche of the share buy-back programme for 2024
-
Equinor ASA: Key information relating to cash dividend for third quarter 2024
-
Teck Reports Unaudited Third Quarter Results for 2024
-
Equinor third quarter 2024 results
-
Hexa appoints GTA as Landing Party in Guam
-
J INTS BIO Presents Interim Findings from Phase 1/2 Clinical Trial of 4th-Generation EGFR-TKI 'JIN-A02' in NSCLC: A Potential Breakthrough in Overcoming Acquired Resistance to Targeted Therapy


